Literature DB >> 26218947

A Best-Evidence Systematic Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal Pain.

Mark V Boswell1, Laxmaiah Manchikanti, Alan D Kaye, Sanjay Bakshi, Christopher G Gharibo, Sanjeeva Gupta, Sachin Sunny Jha, Devi E Nampiaparampil, Thomas T Simopoulos, Joshua A Hirsch.   

Abstract

BACKGROUND: Spinal zygapophysial, or facet, joints are a source of axial spinal pain and referred pain in the extremities. Conventional clinical features and other noninvasive diagnostic modalities are unreliable in diagnosing zygapophysial joint pain. STUDY
DESIGN: A systematic review of the diagnostic accuracy of spinal facet joint nerve blocks.
OBJECTIVE: To determine the diagnostic accuracy of spinal facet joint nerve blocks in chronic spinal pain.
METHODS: A methodological quality assessment of included studies was performed using Quality Appraisal of Reliability Studies (QAREL). Only diagnostic accuracy studies meeting at least 50% of the designated inclusion criteria were utilized for analysis. The level of evidence was classified as Level I to V based on the grading of evidence utilizing best evidence synthesis. Data sources included relevant literature identified through searches of PubMed and other electronic searches published from 1966 through March 2015, Cochrane reviews, and manual searches of the bibliographies of known primary and review articles. OUTCOME MEASURES: Studies must have been performed utilizing controlled local anesthetic blocks. The criterion standard must have been at least 50% pain relief from baseline scores and the ability to perform previously painful movements.
RESULTS: The available evidence is Level I for lumbar facet joint nerve blocks with the inclusion of a total of 17 studies with dual diagnostic blocks, with at least 75% pain relief with an average prevalence of 16% to 41% and false-positive rates of 25% to 44%. The evidence for diagnosis of cervical facet joint pain with cervical facet joint nerve blocks is Level II based on a total of 11 controlled diagnostic accuracy studies, with significant variability among the prevalence in a heterogenous population with internal inconsistency. The prevalence rates ranged from 36% to 67% with at least 80% pain relief as the criterion standard and a false-positive rate of 27% to 63%. The level of evidence for the diagnostic accuracy of thoracic facet joint nerve blocks is Level II with 80% or higher pain relief as the criterion standard with a prevalence ranging from 34% to 48% and false-positive rates ranging from 42% to 48%. LIMITATIONS: The shortcomings of this systematic review include a paucity of literature related to the thoracic spine, continued debate on an appropriate gold standard, appropriateness of diagnostic blocks, and utility.
CONCLUSION: The evidence is Level I for the diagnostic accuracy of lumbar facet joint nerve blocks, Level II for cervical facet joint nerve blocks, and Level II for thoracic facet joint nerve blocks in assessment of chronic spinal pain.

Entities:  

Mesh:

Year:  2015        PMID: 26218947

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  12 in total

Review 1.  Utilization of Facet Joint and Sacroiliac Joint Interventions in Medicare Population from 2000 to 2014: Explosive Growth Continues!

Authors:  Laxmaiah Manchikanti; Joshua A Hirsch; Vidyasagar Pampati; Mark V Boswell
Journal:  Curr Pain Headache Rep       Date:  2016-10

2.  The nosological classification of whiplash-associated disorder: a narrative review.

Authors:  Joe H Ghorayeb
Journal:  J Can Chiropr Assoc       Date:  2021-04

3.  Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.

Authors:  Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao
Journal:  Reg Anesth Pain Med       Date:  2020-04-03       Impact factor: 6.288

Review 4.  Utilization Patterns of Facet Joint Interventions in Managing Spinal Pain: a Retrospective Cohort Study in the US Fee-for-Service Medicare Population.

Authors:  Laxmaiah Manchikanti; Amol Soin; Dharam P Mann; Sanjay Bakshi; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2019-08-06

Review 5.  Pain States, the Opioid Epidemic, and the Role of Radiologists.

Authors:  Mark R Jones; Alan D Kaye; Laxmaiah Manchikanti; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2018-02-23

Review 6.  Management of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal Pain.

Authors:  Salah N El-Tallawy; Rohit Nalamasu; Gehan I Salem; Jo Ann K LeQuang; Joseph V Pergolizzi; Paul J Christo
Journal:  Pain Ther       Date:  2021-02-11

7.  Cost Utility Analysis of Cervical Therapeutic Medial Branch Blocks in Managing Chronic Neck Pain.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Int J Med Sci       Date:  2017-10-15       Impact factor: 3.738

Review 8.  Medial Branch Blocks for Diagnosis of Facet Joint Pain Etiology and Use in Chronic Pain Litigation.

Authors:  Gordon E Lawson; Paul S Nolet; Adam R Little; Anit Bhattacharyya; Vivian Wang; C Adam Lawson; Gordon D Ko
Journal:  Int J Environ Res Public Health       Date:  2020-10-29       Impact factor: 3.390

9.  Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Alan D Kaye; Joshua A Hirsch
Journal:  Korean J Pain       Date:  2018-01-02

10.  Unique aspects of clinical trials of invasive therapies for chronic pain.

Authors:  Steven P Cohen; Mark Wallace; Richard L Rauck; Brett R Stacey
Journal:  Pain Rep       Date:  2018-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.